Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 2 (MTND3P2) is annotated as a mitochondrial pseudogene, meaning it is a non-functional DNA sequence similar to the mitochondrial gene MT-ND3. MTND3P2 does not encode a functional protein and is not known to contribute to any biological process, disease, or therapeutic mechanism. Pseudogenes like MTND3P2 are remnants of gene duplication events or genomic rearrangements and typically do not have regulatory or phenotypic effects. MTND3P2 is distinct from the functional MT-ND3 gene, which encodes a core subunit of the mitochondrial NADH dehydrogenase (Complex I) involved in the electron transport chain. No information exists linking MTND3P2 to any therapeutic, diagnostic, or biological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 2 (MTND3P2).